TickerFacts.

Palvella Therapeutics, Inc. (PVLA): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2016-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest Free Cash Flow is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Capital Expenditures, which Free Cash Flow is computed from, under the concepts TickerFacts maps.

-$13.87M
Year ended 2023-12-31
$47.80M2013-12-31: -$3.13M2014-12-31: -$5.33M2015-12-31: -$13.33M2016-12-31: -$14.95M2017-12-31: $47.80M2018-12-31: -$2.76M2019-12-31: -$54.93M2020-12-31: -$48.62M2021-12-31: -$8.61M2022-12-31: -$60.97M2023-12-31: -$13.87M-$13.87M
2013-12-31 Free Cash Flow (USD) 2023-12-31
Period endedFree Cash FlowChange YoYSource filing
2023-12-31-$13.87Mn/m2025-03-31, From 2023-01-01
2022-12-31-$60.97Mn/m2024-03-29, From 2022-01-01
2021-12-31-$8.61Mn/m2023-03-31, From 2021-01-01
2020-12-31-$48.62Mn/m2022-03-02, From 2020-01-01
2019-12-31-$54.93Mn/m2021-03-31, From 2019-01-01
2018-12-31-$2.76Mn/m2020-03-13, From 2018-01-01
2017-12-31$47.80Mn/m2019-03-18, From 2017-01-01
2016-12-31-$14.95Mn/c2018-03-15, From 2016-01-01
2015-12-31-$13.33Mn/m2017-03-30, From 2015-01-01
2014-12-31-$5.33Mn/m2016-03-23, From 2014-01-01
2013-12-31-$3.13Mn/a2015-03-30, From 2013-01-01